Document is current
Any future updates will be listed below
-
Authors
Mendoza-Santiesteban, Carlos E. https://orcid.org/0000-0002-6344-4544
Tran, Amanda https://orcid.org/0009-0001-5756-7038
Albertos-Arranz, Henar https://orcid.org/0000-0001-8656-9887
Mendoza-Infante, Ximena
Mendoza-Hung, Nicole M. https://orcid.org/0009-0005-2677-7293
Clifford, Paul R.
Ricur, Giselle https://orcid.org/0000-0003-0835-9715
Del-Campo, Ioannis https://orcid.org/0009-0006-4373-3089
Juvier-Riesgo, Tamara https://orcid.org/0000-0002-5954-7233
- License Information
-
More Information
Article History
Received: 7 October 2025
Revised: 23 January 2026
Accepted: 2 February 2026
First Online: 16 February 2026
Declarations
:
: The study was approved by The University of Miami Miller School of Medicine Institutional Review Board/Ethics Committee of the Bascom Palmer Eye Institute, which adheres to the tenets of the Declaration of Helsinki and the Health Insurance Portability and Accountability Act (HIPAA).
: Written informed consent was obtained from all participants before enrollment.
: Dr. CEMS is a compensated consultant for and equity holder in Olleyes, Inc., manufacturer of the device being used in the study. The other authors declare no competing interests.
